Device Thrombogenicty Emulator (DTE) – Design optimization Methodology for Cardiovascular Devices: A Study in Two Bileaflet MHV Designs

Patients who receive prosthetic heart valve (PHV) implants require mandatory anticoagulation medication after implantation due to the thrombogenic potential of the valve. Optimization of PHV designs may facilitate reduction of flow-induced thrombogenicity and reduce or eliminate the need for post-im...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Xenos, Michalis, Girdhar, Gaurav, Alemu, Yared, Jesty, Jolyon, Slepian, Marvin, Einav, Shmuel, Bluestein, Danny
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922449/
https://ncbi.nlm.nih.gov/pubmed/20483411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiomech.2010.04.020
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi